Coloplast A/S Revised Full Year Organic Growth and EBIT Margin Guidance for 2019/2020 Call Transcript
Ladies and gentlemen, thank you all for standing by, and welcome to today's Coloplast announcement. (Operator Instructions) I must advise you all that this conference is being recorded today, Thursday, the 19th of March 2020.
And without any further delay, I would like to hand the conference to your speaker today, the CEO, Kristian Villumsen. Please go ahead, sir.
/-&
Thank you very much, operator, and good morning to everybody, and welcome to this morning's conference call. I'm Kristian Villumsen, CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. I'll start with a few opening remarks, and then Anders and I will open up for questions.
Last night, we issued a stock exchange announcement and revised our guidance for our financial year 2019/'20. These are no ordinary times. We're seeing the coronavirus spread across the world and the situation is developing rapidly.
Our priorities are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |